The pharma sector has shown significant growth during the past three years. In 2015, 767 million packages of medicines produced in Ukraine were sold locally, demonstrating a good balance between the quality and price of domestic production. Another important point is that the development of Ukraine's industrial infrastructure has also increased demand for locally produced medicines.
In the final publication of Delo.UA and Redcliffe Partners' joint “5x5” project, partner Dmytro Fedoruk discusses the major M&A deals in, and the impact of EU law, on Ukraine's pharma sector.
Full text is available in Russian. Read more